Project: Screening of CTP Synthase Inhibitors to Augment Antiviral Drugs for the Synergistic Treatment of COVID-19 Infections [Funder: NSHA Research & Innovation, Dalhousie Medical Research Foundation, QEII Health Sciences Centre Foundation, IWK Foundation, DGHF, RNS]
- Funded by Other Funders (Canada)
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Funder
Other Funders (Canada)Principal Investigator
Dr Stephen Bearne Stephen BearneResearch Location
CanadaLead Research Institution
Dalhousie UniversityResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementation
Research Subcategory
Pre-clinical studies
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
This study will rapidly assess the potential of active derivatives of known antiviral drug compounds to inhibit the production of one of the building blocks the COVID-19 virus requires to replicate itself.